Vevo Therapeutics

company

About

Vevo Therapeutics that is combining in vivo data generated at scale with AI to find better targets and drugs to treat more patients.

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$12M
Industries
Artificial Intelligence,Biotechnology,Therapeutics
Founded date
Jan 1, 2022
Number Of Employee
11 - 50
Operating Status
Active

Vevo Therapeutics, a biotechnology startup, searches for better treatments for more patients using their Mosaic in vivo drug discovery platform and next-generation AI algorithms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$12M
Vevo Therapeutics has raised a total of $12M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2022 Seed $12M 1 General Catalyst Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Vevo Therapeutics is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Yes Seed